3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Lymphoid
2
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
1363
Lung Neoplasms
697
Small Cell Lung Carcinoma
202
Neoplasms
151
Neoplasm Metastasis
130
Breast Neoplasms
116
Melanoma
99
Colorectal Neoplasms
84
Adenocarcinoma of Lung
84
Ovarian Neoplasms
78
Pancreatic Neoplasms
72
Carcinoma, Renal Cell
69
Head and Neck Neoplasms
66
Mesothelioma
58
Prostatic Neoplasms
53
Urinary Bladder Neoplasms
52
Mesothelioma, Malignant
51
Stomach Neoplasms
47
Triple Negative Breast Neoplasms
45
Carcinoma
45
Esophageal Neoplasms
43
Brain Neoplasms
42
Squamous Cell Carcinoma of Head and Neck
41
Colonic Neoplasms
35
Sarcoma
34
Adenocarcinoma, Bronchiolo-Alveolar
33
Recurrence
32
Adenocarcinoma
31
Uterine Cervical Neoplasms
30
Parkinson Disease 4, Autosomal Dominant Lewy Body
29
Interventions
pembrolizumab
1
GSK-3326595
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Thoracic
×
Clear all
NCT02783300
2025-03-10
Meteor 1
GlaxoSmithKline
Phase 1
Completed
297 enrolled
76 charts